Wells Fargo & Company Danaher Corp Call Options Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$185.1 - $233.13 $7.4 Million - $9.33 Million
40,000 Added 4000.0%
41,000 $9.48 Million
Q2 2023

Aug 15, 2023
SELL
$224.99 - $256.14 $1.84 Million - $2.1 Million
-8,200 Reduced 89.13%
1,000 $240,000
Q1 2023

May 12, 2023
BUY
$239.75 - $277.0 $2.06 Million - $2.38 Million
8,600 Added 1433.33%
9,200 $2.32 Million
Q4 2022

Feb 13, 2023
BUY
$241.42 - $282.29 $144,852 - $169,374
600 New
600 $159,000

Others Institutions Holding DHR

# of Institutions
2,509
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email